Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novel drug molecule could help treat Parkinson's disease in young patients
More than 100,000 Canadians currently live with Parkinson's disease. A novel drug molecule being studied by researchers from McGill University could reactivate housekeeping functions in brain cells of young Parkinson's patients,
How COVID affected teens' brains, plus new cancer drugs and Parkinson's risk
The Fox News Health Newsletter brings you trending and important stories about health warnings, drug shortages, mental health issues and more in this weekly recap.
Some diabetes meds might lower risk of dementia, Parkinson's
A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.
Diabetes drugs may protect against dementia
New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.
These Diabetes Drugs Could Help Lower Your Risk of Dementia, Parkinson’s
According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or SGLT2 inhibitors, stop the kidneys from reabsorbing too much blood glucose to improve blood sugar levels.
Type 2 drugs could lower dementia, Parkinson's disease risk
Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk of dementia, overall, and of Alzheimer's disease and Parkinson's, in particular.
Some diabetes drugs tied to lower risk of dementia, Parkinson's disease
A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new study.
Research shows diabetes drug could reduce dementia risk. Here’s how the two diseases may be linked
Some diabetes medications linked to lower dementia, Parkinson's disease risk
Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By encouraging the kidneys to eliminate sugar from the body through urine, they reduce blood sugar.
WMNF
2d
USF researcher integral part of FDA’s approval of new Parkinson’s drug
The cause of Parkinson's Disease remains largely unknown, but a new drug could be extremely beneficial to treat symptoms.
technologynetworks
2d
New Drug Molecule Offers Hope for Treating Early-Onset Parkinson’s Disease
New research suggests that a novel drug molecule could lead to treatments preventing Parkinson’s disease in younger patients.
Armed robbery in Revesby
2d
New Drug Molecule May Offer Young Parkinson's Patients Hope
A novel drug molecule could potentially lead to new treatments to prevent Parkinson's disease in younger patients, according ...
News Medical
5d
New microscopy technique detects early Parkinson's disease indicators
Researchers at Tel Aviv University cooperated with three major Israeli medical centers to develop a new method for detecting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback